News
In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback